4//SEC Filing
Sucampo Pharmaceuticals, Inc. 4
Accession 0001171843-13-005083
CIK 0001365216operating
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 7:34 PM ET
Size
8.5 KB
Accession
0001171843-13-005083
Insider Transaction Report
Form 4
Dolecek Gayle R
DirectorVP of Research & Development
Transactions
- Exercise of In-Money
Employee Stock Option (Right to Buy)
2013-12-16$8.00/sh−45,000$360,000→ 332,700 totalExercise: $4.41From: 2013-06-04Exp: 2021-05-02→ Class A Common Stock (45,000 underlying) - Exercise of In-Money
Class A Common Stock
2013-12-16$8.00/sh−54,400$435,200→ 332,700 total - Exercise of In-Money
Employee Stock Option (Right to Buy)
2013-12-16$8.00/sh−9,400$75,200→ 377,700 totalExercise: $4.41From: 2012-05-02Exp: 2021-05-02→ Class A Common Stock (9,400 underlying)
Footnotes (1)
- [F1]The date exercisable for a portion of the stock options is 6/4/2013.
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeoperating
Related Parties
1- filerCIK 0001365216
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 7:34 PM ET
- Size
- 8.5 KB